Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 27, 2018Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system
Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in Santa Rosa, Calif., upon its recent...
-
Dec 21, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 in San Francisco, California. Mike Mahoney, chairman and...
-
Dec 11, 2018Delaware Court Rules Edwards Lifesciences Infringes Boston Scientific Patent
Boston Scientific Corporation (NYSE: BSX) today announced that a jury in the United States (U.S.) District Court for the District of Delaware determined that the Boston Scientific U.S. patent...
-
Dec 3, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018 in New York City. Susie...
-
Nov 27, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York City. Art Butcher, senior vice president and...
-
Nov 25, 2018
Patient safety is Boston Scientific’s highest priority and our constant focus in helping care for people living with complex, debilitating and often life-threatening conditions. We provide...
-
Nov 21, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 30th Annual Piper Jaffray Healthcare Conference on Thursday, November 29, 2018 in New York City. Jeff Mirviss, senior vice...
-
Nov 20, 2018Transaction would expand peripheral interventions portfolio with minimally-invasive treatments for cancers and vascular conditions
Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. (LSE: BTG), a company headquartered in the United Kingdom, which...
-
Nov 7, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City. David Pierce,...
-
Nov 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York City. Dan Brennan, executive vice president and chief...
-
Nov 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, Arizona. Joe Fitzgerald, executive...
-
Oct 24, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.393 billion during the third quarter ended September 30, 2018. This represents growth of 7.7 percent on a reported basis, 9.1...
-
Oct 23, 2018Court Rules Edwards Lifesciences' Next-Generation Valve Infringes Boston Scientific Patent and Grants Right to Enjoin Sales in Germany
Boston Scientific Corporation (NYSE: BSX) today announced the District Court of Dusseldorf, Germany has determined that Edwards Lifesciences Corporation's Sapien 3 Ultra™ device infringed a...
-
Oct 16, 2018
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed and commercialized the SpaceOAR® Hydrogel System...
-
Oct 10, 2018Data Support Minimally Invasive Single-Incision Mesh Procedure as a Durable, Safe and Effective Treatment for Stress Urinary Incontinence, a Condition that Affects 18 Million American Adults
CHICAGO and MARLBOROUGH, Mass., Oct. 10, 2018 -- Boston Scientific Corporation (NYSE: BSX) today announced that its Solyx™ Single Incision Sling (SIS) System achieved treatment success, meeting...
-
Oct 1, 2018Fourth annual Connected Patient Challenge focuses on utilizing population health data, patient monitoring or predictive analytics to improve patient care and lower healthcare costs
MARLBOROUGH, Mass., Oct. 1, 2018– Boston Scientific Corporation (NYSE: BSX) today announced a worldwide call for submissions to the fourth annual Boston Scientific Connected Patient Challenge,...
-
Oct 1, 2018
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2018 on Wednesday, October...
-
Sep 24, 2018First peripheral vascular interventional technology approved in the U.S. to offer sustained release of antiproliferative drug to treat patients with peripheral artery disease
Today, Boston Scientific (NYSE: BSX) announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia™ Drug-Eluting Vascular...
-
Sep 22, 2018First head-to-head trial assesses effectiveness of sustained drug release in interventional treatment for patients with blockages in femoropopliteal arteries
Today, Boston Scientific (NYSE: BSX) announced positive 12-month data from the IMPERIAL trial, the first head-to-head drug-eluting stent trial in the superficial femoral artery (SFA). Results were...
-
Sep 21, 2018New Data at World Congress of Endourology Demonstrate the LithoVue Empower Device Improves OR Experience
Boston Scientific Corporation (NYSE: BSX) today announced the global launch of the LithoVue Empower™ Retrieval Deployment Device, designed to be used with the LithoVue™ Single-Use Digital...
-
Sep 17, 2018
Boston Scientific Corporation (NYSE: BSX) today announced key data that will be presented at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the...
-
Sep 6, 2018Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients
Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the...
-
Sep 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Thursday, September 13, 2018 in New York City. Mike Mahoney, chairman...
-
Aug 29, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 13th Annual Wells Fargo Securities Healthcare Conference on Wednesday, September 5, 2018 in Boston. Susie Lisa, vice...
-
Aug 8, 2018Acquisition to Bolster Company's Venous Therapies Portfolio within Peripheral Interventions Division
Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire VENITI, Inc., a privately-held company in Fremont, California which has developed and commercialized...
-
Aug 2, 2018CMS Grants NTAP Designation for The Sentinel® Cerebral Protection System
Boston Scientific Corporation (NYSE: BSX) announced it has recently closed its acquisition of Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel®...
-
Jul 30, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 38th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston. Susie Lisa, vice president,...
-
Jul 25, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.490 billion during the second quarter ended June 30, 2018. This represents growth of 10.3 percent on a reported basis, 8.6 percent...
-
Jul 24, 2018
Boston Scientific Corporation (NYSE: BSX) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation (TRC) to purchase up to three million shares of Boston Scientific's...
-
Jul 20, 2018Addition of FDA-cleared Sentinel® Cerebral Embolic Protection System to Expand Company's Structural Heart Offerings
Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel®...
-
Jul 5, 2018Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform
Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company developing a single-shot cryoablation platform for the...
-
Jul 2, 2018
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2018 on Wednesday, July 25,...
-
Jun 1, 2018
Boston Scientific (NYSE: BSX) today announced key data that will be presented at Digestive Disease Week (DDW) being held in Washington D.C., June 2 to June 5. The annual meeting is the largest...
-
May 16, 2018
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of key presentations, including two late-breaking clinical trials, that will be featured at the annual EuroPCR Scientific...
-
May 14, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 34th Annual Strategic Decisions Conference on May 31, 2018 in New York. Mike Mahoney, chairman and chief executive...
-
May 13, 2018Read the facts about our pelvic floor products
The CBS network television show “60 Minutes” recently aired an investigative story with completely false claims that suggested that our transvaginal mesh products contain counterfeited and smuggled materials. We want you to know the facts and understand our perspective.
-
May 11, 2018Late-Breaker Data Highlight Reduction in Rate of Inappropriate Shocks with Sensing Filter
Boston Scientific (NYSE: BSX) today announced results from an analysis of the LATITUDE database which evaluated the successful reduction of inappropriate shocks using the SMART Pass sensing filter...
-
May 7, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2018 Health Care Conference on May 16, 2018 in Las Vegas. Dan Brennan, executive vice...
-
Apr 30, 2018
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the Rezūm® system, a minimally invasive therapy (MIT) for patients with...
-
Apr 25, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.379 billion during the first quarter ended March 31, 2018. This represents growth of 10.1 percent on a reported basis, 6.2 percent...
-
Apr 24, 2018
Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, multi-center study of...
-
Apr 16, 2018European Patent Office Revokes Edwards Lifesciences '550 Patent
Boston Scientific Corporation (NYSE: BSX) today announced that it, along with several other opponents, successfully opposed Edwards Lifesciences Corporation's European patent EP 2,399,550 ('550)...
-
Apr 16, 2018Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer
Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health. nVision developed the first and only device...
-
Apr 3, 2018Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor
Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Securus Medical Group, Inc., a privately-held company that has developed a thermal monitoring system for the continuous...
-
Mar 28, 2018U.K. Court Affirms that Edwards Lifesciences Infringes Boston Scientific Patent
Boston Scientific Corporation (NYSE: BSX) today announced the U.K. Court of Appeal dismissed Edwards Lifesciences' appeal and upheld a prior court decision that Edwards' Sapien 3™ device...
-
Mar 26, 2018
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2018 on Wednesday, April 25,...
-
Mar 21, 2018Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia
Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire NxThera, a privately-held company based in Maple Grove, Minnesota. NxThera developed and...
-
Mar 20, 2018
Boston Scientific Corporation (NYSE: BSX) announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm...
-
Mar 14, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018 in New York City. Susie Lisa, vice president,...
-
Mar 12, 2018
Boston Scientific Corporation (NYSE: BSX) today announced key data presentations that will be featured at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain,...
-
Mar 5, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the Barclays Global Healthcare Conference on March 13 in Miami Beach, Florida. Dan Brennan, executive vice president and chief...
-
Mar 5, 2018Acquisition expands endoscopic portfolio to include radiofrequency devices
Boston Scientific (NYSE: BSX) today announced that it has acquired EMcision, Limited, a privately held company located in the United Kingdom and Canada. The acquisition will expand the Boston...
-
Feb 26, 2018
Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due March 1, 2028. The Company previously announced that...
-
Feb 22, 2018
Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due March 1, 2028 under the company's...
-
Feb 1, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.408 billion during the fourth quarter ended December 31, 2017. This represents growth of 9.9 percent on a reported basis and 8.1...
-
Jan 29, 2018
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the LEERINK Partners 7th Annual Global Healthcare Conference on February 15, 2018 in New York. Dan Brennan, executive vice...
-
Jan 24, 2018
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in...
-
Jan 24, 2018Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation
Boston Scientific Corporation (NYSE: BSX) today announced it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately-held company that has...
-
Jan 19, 2018
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2017 on Thursday, February...
-
Jan 12, 2018Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation
Boston Scientific Corporation (NYSE: BSX) today announced positive results from the WHISPER randomized controlled trial (RCT). The data, presented at the 2018 Annual Meeting of the North American...
-
Jan 11, 2018System offers non-opioid treatment option with multiple therapies for people with chronic pain
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System. It is the...
-
Jan 9, 2018
Boston Scientific Corporation (NYSE: BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.41 billion during the fourth quarter ended December 31, 2017....
-
Dec 22, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 36th annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 in San Francisco, CA. Mike Mahoney, chairman...
-
Dec 21, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 4, 2018 in Boston, MA. Mike Mahoney, chairman...
-
Dec 11, 2017Platform Offers Physicians Advanced Technology to Treat Symptoms of Parkinson's disease
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the Vercise™ Deep Brain Stimulation (DBS) System. DBS...
-
Dec 4, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, 2017 in New York. Susie Lisa, vice president,...
-
Nov 28, 2017
Boston Scientific (NYSE: BSX) announces a delay to previously communicated timelines for commercialization of the LOTUS Edge™ Aortic Valve System* in Europe and the U.S. After initiating a...
-
Nov 27, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the Citi 2017 Global Healthcare Conference on December 7, 2017 in New York. Kevin Ballinger, executive vice president and president,...
-
Nov 13, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the Piper Jaffray 29th Annual Healthcare Conference on November 28, 2017 in New York. Susie Lisa, vice president, investor relations...
-
Nov 8, 2017American Heart Association, American College of Cardiology and Heart Rhythm Society Issue Updated Guidelines Underscoring Benefits of the S-ICD System
Updated guidelines issued by the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) now formally recommend the use of a subcutaneous...
-
Nov 8, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the Stifel 2017 Healthcare Conference on November 14, 2017 in New York. Dan Brennan, executive vice president and chief financial...
-
Nov 6, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the 26th Annual Credit Suisse Healthcare Conference on November 7, 2017 in Scottsdale, Arizona. Joe Fitzgerald, executive vice...
-
Nov 2, 2017Late-breaking Clinical Trial Data Presented at TCT 2017 with Simultaneous Publication in the Journal of the American College of Cardiology
Boston Scientific (NYSE: BSX) announced final five-year outcomes data from the PREVAIL study of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical...
-
Oct 26, 2017
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.222 billion during the third quarter ended September 30, 2017. This represents growth of 5.6 percent on a reported basis and 5.7...
-
Oct 23, 2017
Boston Scientific (NYSE: BSX) today announced key data that will be presented at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular...
-
Oct 4, 2017
Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Desiree Ralls-Morrison as senior vice president, general counsel and corporate secretary. Ralls-Morrison will join...
-
Oct 2, 2017Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial Fibrillation
Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon...
-
Oct 2, 2017
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2017 on Thursday, October...
-
Sep 25, 2017
Boston Scientific (NYSE: BSX) has launched the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems featuring the...
-
Sep 19, 2017Data Presented at Heart Failure Society of America's 21st Annual Scientific Meeting Demonstrate Alert Improves Heart Failure Risk Prediction
Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the performance of the...
-
Sep 18, 2017Patients with Severe Asthma Show Sustained Clinical Improvement
Boston Scientific (NYSE: BSX) today announced results from a three year follow-up cohort in its Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma...
-
Aug 28, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the Morgan Stanley Global Healthcare Conference on September 12, 2017 in New York City. Mike Mahoney, chairman and chief executive...
-
Aug 21, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wells Fargo Healthcare Conference on September 7, 2017 in Boston. Susie Lisa, vice president, Investor Relations, will...
-
Jul 31, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Canaccord Genuity Growth Conference on August 9, 2017 in Boston. Boston Scientific investor relations representatives,...
-
Jul 27, 2017
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.257 billion during the second quarter ended June 30, 2017. This represents growth of 6 percent on a reported basis and 7 percent on...
-
Jul 5, 2017
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2017 on Thursday, July 27, 2017 at
-
Jun 27, 2017
Boston Scientific Corporation (NYSE: BSX) is hosting a meeting with the investment community today in New York City to provide an overview of its business and long-term growth strategies. Chairman...
-
Jun 6, 2017Industry's First MR-Conditional Directional DBS System with Stimulation Visualization
Boston Scientific (NYSE: BSX) has received CE mark for the Vercise™ Gevia™ Deep Brain Stimulation (DBS) System*, a rechargeable, magnetic resonance (MR) conditional device indicated for the...
-
May 24, 2017Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference
Boston Scientific (NYSE: BSX) today announced positive results from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma (PAS2) study evaluating...
-
May 17, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2017 UBS Global Healthcare Conference on Tuesday, May 23, 2017 in New York City. Susie Lisa, vice president, investor...
-
May 16, 2017
Boston Scientific (NYSE: BSX) today announced positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris. Data from the study demonstrated...
-
May 16, 2017Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter...
-
May 12, 2017Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017
Boston Scientific (NYSE: BSX) today announced positive safety and efficacy rates of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry presented during a...
-
May 12, 2017Analyses Evaluated the Impact of Ethnicity, Gender and Income on Cardiovascular Outcomes
New analyses from the Boston Scientific Corporation (NYSE: BSX) sponsored PLATINUM Diversity study underscore the need for greater understanding of the clinical and nonclinical barriers that can...
-
May 11, 2017Late-Breaker Data Presented at Heart Rhythm 2017
Boston Scientific (NYSE: BSX) today announced results from the U.S. post-market approval study evaluating 'real-world' patients implanted with the Subcutaneous Implantable Defibrillator (S-ICD)...
-
May 10, 2017Pivotal Data From REPRISE III and EWOLUTION Among Four Late-breaking Clinical Trials to be Presented
Boston Scientific (NYSE: BSX) today announced the schedule of key data presentations, including four late-breaking clinical trials, that will be featured at the annual EuroPCR Scientific Program,...
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization...
-
May 3, 2017Late-Breaking Clinical Trials Feature Subcutaneous Implantable Defibrillator and WATCHMAN™ Left Atrial Appendage Closure Device
Boston Scientific (NYSE: BSX) today announced the schedule of key data presentations, including two late-breaking clinical trials, that will be featured at the 38th Annual Scientific Sessions of...
-
May 1, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017 Healthcare Conference on Thursday, May 18, 2017 in Las Vegas. Susie Lisa, vice...
-
Apr 27, 2017
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.160 billion during the first quarter ended March 31, 2017. This represents growth of 10 percent compared to the prior year period on...